26.04.2012
- The Federal Trade Commission on Wednesday lost its latest attempt to thwart deals to delay the production of cheaper, generic drugs that brand-name drug companies make with...
25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
23.04.2012
- Europe's largest drugs distributor Celesio is set to significantly boost its stake in Brazil's largest drugs distributor Panpharma from currently 50.1%, two people with the matter...
23.04.2012
- Australian flu drug maker Biota Holdings has agreed to take over U.S. firm Nabi Biopharmaceuticals to create a $258 million group and move to the United States, where investors...
20.04.2012
- European regulators have endorsed the continued use of Novartis's multiple sclerosis pill Gilenya, one of the Swiss firm's top new drug hopes, but said on Friday the drug needed to...
20.04.2012
- Roche dropped its bid to buy the gene-sequencing leader Illumina this week after Illumina's shareholders made it clear at the company's annual meeting that the terms were...
20.04.2012
- Watchdog group Public Citizen urged U.S. regulators to withdraw approval of Novo Nordisk's diabetes drug Victoza, saying it increases the risk of serious health problems like...
19.04.2012
- Europe's largest biotech company Actelion said it expects results of a key late-stage trial on heart and lung disease drug macitentan in the next few weeks after a strong Swiss...
